Patents Assigned to Amdl, Inc.
  • Publication number: 20100316603
    Abstract: The present invention provides to immunogene therapy protocols for the treatment of tumors. In particular, the present invention provides combinations of immune-modulating proteins that induce systemic immunity against tumors. In addition, the present invention provides humanized animal models suitable for the evaluation of anti-human tumor immunity and permit the identification of combinations of immune-modulating genes which when delivered to human tumor cells induce an effective anti-tumor response, including a systemic anti-tumor response.
    Type: Application
    Filed: August 5, 2010
    Publication date: December 16, 2010
    Applicant: AMDL, Inc.
    Inventor: Lung-Ji Chang
  • Patent number: 6730512
    Abstract: The present invention provides to immunogene therapy protocols for the treatment of tumors. In particular, the present invention provides combinations of immune-modulating proteins that induce systemic immunity against tumors. In addition, the present invention provides humanized animal models suitable for the evaluation of anti-human tumor immunity and permit the identification of combinations of immune-modulating genes which when delivered to human tumor cells induce an effective anti-tumor response, including a systemic anti-tumor response.
    Type: Grant
    Filed: April 4, 2001
    Date of Patent: May 4, 2004
    Assignee: Amdl, Inc.
    Inventor: Lung-Ji Chang
  • Patent number: 5635605
    Abstract: A method is described for identifying, localizing and treating tumors in a patient. The method comprises assaying extracellular fluids, isolated from a patient, for the presence of elevated levels of ring shaped particles (RSP). The assay employs binding labeled RSP specific binding agent to the RSP.
    Type: Grant
    Filed: March 6, 1995
    Date of Patent: June 3, 1997
    Assignee: AMDL, Inc.
    Inventors: Robert R. Guerrero, Donald E. Rounds
  • Patent number: 5459035
    Abstract: A method is described for identifying and localizing tumors in a patient. The method comprises assaying extracellular fluids, isolated from a patient, for the presence of elevated levels of ring shaped particles (RSP). The assay employs binding labeled RSP specific binding agent to the RSP.
    Type: Grant
    Filed: December 9, 1992
    Date of Patent: October 17, 1995
    Assignee: AMDL, Inc.
    Inventors: Robert R. Guerrero, Donald E. Rounds